We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
+$3.66B
Cap. Flow
+$2.96B
Cap. Flow %
2.88%
Top 10 Hldgs %
12.16%
Holding
4,809
New
469
Increased
2,314
Reduced
1,430
Closed
297

Sector Composition

Rank Sector Weight
1 Financials 13.25%
2 Healthcare 11.22%
3 Technology 10.98%
4 Industrials 7.83%
5 Energy 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHH
2201
DELISTED
PHH Corporation
PHH
$2.73M ﹤0.01%
104,821
+47,993
+84% +$1.25M
UBSI icon
2202
United Bankshares
UBSI
$6.63B
$2.73M ﹤0.01%
67,751
+10,106
+18% +$386K
CLF icon
2203
Cleveland-Cliffs
CLF
$6.57B
$2.72M ﹤0.01%
628,736
-6,410
-1% -$34.1K
AOM icon
2204
iShares Core Moderate Allocation ETF
AOM
$1.74B
$2.72M ﹤0.01%
+77,145
New +$2.76M
LUMO
2205
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.71M ﹤0.01%
6,794
+2,865
+73% +$1.22M
CONE
2206
DELISTED
CyrusOne Inc Common Stock
CONE
$2.7M ﹤0.01%
91,805
+64,003
+230% +$2M
LPLA icon
2207
LPL Financial
LPLA
$28.3B
$2.7M ﹤0.01%
58,105
-76,062
-57% -$3.29M
CAA
2208
DELISTED
CalAtlantic Group, Inc.
CAA
$2.7M ﹤0.01%
60,653
+12,443
+26% +$529K
TARO
2209
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.7M ﹤0.01%
18,777
-31,276
-62% -$4.46M
AMRI
2210
DELISTED
Albany Molecular Research Inc
AMRI
$2.7M ﹤0.01%
133,394
+85,518
+179% +$1.65M
CFD
2211
DELISTED
Nuveen Diversified Commodity Fnd
CFD
$2.69M ﹤0.01%
226,080
OMCL icon
2212
Omnicell
OMCL
$1.61B
$2.69M ﹤0.01%
71,375
+47,770
+202% +$1.74M
ENDP
2213
PUT
DELISTED
Endo International plc
ENDP
$2.68M ﹤0.01%
33,700
BT
2214
DELISTED
BT Group plc (ADR)
BT
$2.68M ﹤0.01%
75,622
-202,270
-73% -$7.07M
HAWK
2215
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$2.68M ﹤0.01%
65,045
+1,340
+2% +$50K
INXN
2216
DELISTED
Interxion Holding N.V.
INXN
$2.67M ﹤0.01%
96,544
-106,118
-52% -$3.15M
GSAT icon
2217
Globalstar
GSAT
$10.7B
$2.67M ﹤0.01%
84,241
-27,269
-24% -$1.06M
FLGE
2218
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
$2.66M ﹤0.01%
21,905
-6,794
-24% -$853K
DCH
2219
Dauch Corp
DCH
$1.34B
$2.65M ﹤0.01%
126,952
-3,979
-3% -$96.1K
IEP icon
2220
Icahn Enterprises
IEP
$5.24B
$2.65M ﹤0.01%
30,524
+460
+2% +$41.5K
MHR
2221
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
$2.64M ﹤0.01%
1,413,348
+615,537
+77% +$1.22M
DNOW icon
2222
DNOW Inc
DNOW
$2.58B
$2.64M ﹤0.01%
132,627
-683,137
-84% -$15.6M
CTB
2223
DELISTED
Cooper Tire & Rubber Co.
CTB
$2.64M ﹤0.01%
78,001
+43,338
+125% +$1.67M
TIVO
2224
DELISTED
TIVO INC
TIVO
$2.64M ﹤0.01%
259,998
+25,245
+11% +$273K
IGSB icon
2225
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$2.63M ﹤0.01%
50,020
-81,896
-62% -$4.32M

Similar funds

Credit Suisse's Q2 2015 Portfolio in Review

As of Q2 2015, Credit Suisse held 4,809 positions worth $103B, up 3.7% from $99B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Credit Suisse's Q2 2015 filing shows 469 new, 2,314 increased, 1,430 reduced and 297 closed positions. Its largest new stake was UBS Group: 120,749,322 shares worth $2.56B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

  • Credit Suisse's largest Q2 2015 buy was UBS Group: 120,749,322 shares worth $2.56B.
  • Credit Suisse added most to iShares MSCI Emerging Markets ETF in Q2 2015, an estimated $343M increase.
  • Credit Suisse's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
  • Credit Suisse fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $101M.
  • Credit Suisse's ten largest holdings make up 12% of its $103B portfolio in Q2 2015.
  • Credit Suisse opened 469 new positions and closed 297 in Q2 2015.
  • Credit Suisse's portfolio value rose 3.7% quarter-over-quarter to $103B.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.